Category: Health & Medicines > Medicines > Loratadine
Country/Region: China
Main Products: Huperzine A, Clindamycin Hcl, Clindamycin Phosphate, Loratadine, Gingko Biloba Pills, Bronhexine Hcl, 4-piperidine Methanol, Huperzine A
Business Type: Manufacturer
Business Nature: Manufacturer
Year Established: 2001, 2001
Legal Status: Third Party
Ownership: Private Limited
Employees: 501 - 1000 People
Factory Size: 1, 000-3, 000 square meters
R&D Team Size: 51 - 100 People
Certifications: SA8000
Contact Person: Wei Cheng
Designation: Managing Partner
Department: General Manager
Telephone: 86-576-86111357
Main Markets: Australia (28%) United Kingdom (19%) Germany (19%) Canada (18%) Netherlands (10%)
Export Focus: Australia, Canada, Germany, Netherlands, United Kingdom
Contract Services: Buyer Label Offered
Annual Revenue: Approx 0.8 Million US Dollar
Registered Capital: Above US$100 Million
Export Percentage: 91% - 100%
Payment Terms: Bank wire (T/T), Doc Against Payment (D/P), PayPal, Western Union (WU)